Nightingale Cardiology is starting a new research trial for adolescents aged 12-17 with prediabetes, hypertension, or high triglycerides.

Examines the effects of retatrutide weekly injection in patients with established kidney disease.

Examines the effects of small interfering RNA molecule that reduces LPa on Cardiovascular outcomes in patients with raised Lpa and cardiovascular disease.

Examines the effects of ziltivikimab monthly injection on microvascular inflammation and outcomes in Heart failure in heart failure patients with active inflammation.